nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—SLC22A6—Conjugated Estrogens—osteoporosis	0.128	1	CbGbCtD
Nalidixic Acid—Anaphylactoid reaction—Pamidronate—osteoporosis	0.00502	0.00575	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Etidronic acid—osteoporosis	0.00489	0.00561	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Estropipate—osteoporosis	0.00488	0.0056	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.00486	0.00558	CcSEcCtD
Nalidixic Acid—Swelling—Conjugated Estrogens—osteoporosis	0.00484	0.00555	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Pamidronate—osteoporosis	0.00474	0.00544	CcSEcCtD
Nalidixic Acid—Drowsiness—Calcitriol—osteoporosis	0.00467	0.00536	CcSEcCtD
Nalidixic Acid—Injury—Conjugated Estrogens—osteoporosis	0.00465	0.00533	CcSEcCtD
Nalidixic Acid—Erythema—Etidronic acid—osteoporosis	0.0045	0.00516	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Conjugated Estrogens—osteoporosis	0.00447	0.00513	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Conjugated Estrogens—osteoporosis	0.00441	0.00506	CcSEcCtD
Nalidixic Acid—Visual impairment—Estropipate—osteoporosis	0.00431	0.00494	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Estropipate—osteoporosis	0.00423	0.00485	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Alendronate—osteoporosis	0.00416	0.00478	CcSEcCtD
Nalidixic Acid—Angioedema—Etidronic acid—osteoporosis	0.00411	0.00472	CcSEcCtD
Nalidixic Acid—Leukopenia—Etidronic acid—osteoporosis	0.00403	0.00462	CcSEcCtD
Nalidixic Acid—Asthenia—Calcium Acetate—osteoporosis	0.00401	0.0046	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Calcitriol—osteoporosis	0.00397	0.00455	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Ethinyl Estradiol—osteoporosis	0.00396	0.00454	CcSEcCtD
Nalidixic Acid—Pruritus—Calcium Acetate—osteoporosis	0.00396	0.00454	CcSEcCtD
Nalidixic Acid—Erythema—Estropipate—osteoporosis	0.00389	0.00446	CcSEcCtD
Nalidixic Acid—Swelling—Estradiol—osteoporosis	0.00387	0.00444	CcSEcCtD
Nalidixic Acid—Erythema—Alendronate—osteoporosis	0.00383	0.0044	CcSEcCtD
Nalidixic Acid—Arthralgia—Etidronic acid—osteoporosis	0.00383	0.00439	CcSEcCtD
Nalidixic Acid—Diarrhoea—Calcium Acetate—osteoporosis	0.00383	0.00439	CcSEcCtD
Nalidixic Acid—Erythema—Ibandronate—osteoporosis	0.00373	0.00428	CcSEcCtD
Nalidixic Acid—Injury—Estradiol—osteoporosis	0.00372	0.00427	CcSEcCtD
Nalidixic Acid—Dizziness—Calcium Acetate—osteoporosis	0.0037	0.00424	CcSEcCtD
Nalidixic Acid—Erythema—Calcitriol—osteoporosis	0.00365	0.00419	CcSEcCtD
Nalidixic Acid—Angioedema—Estropipate—osteoporosis	0.00356	0.00408	CcSEcCtD
Nalidixic Acid—Vomiting—Calcium Acetate—osteoporosis	0.00356	0.00408	CcSEcCtD
Nalidixic Acid—Asthenia—Ergocalciferol—osteoporosis	0.00354	0.00407	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Estradiol—osteoporosis	0.00353	0.00405	CcSEcCtD
Nalidixic Acid—Angioedema—Alendronate—osteoporosis	0.0035	0.00402	CcSEcCtD
Nalidixic Acid—Vertigo—Estropipate—osteoporosis	0.0035	0.00401	CcSEcCtD
Nalidixic Acid—Visual impairment—Ethinyl Estradiol—osteoporosis	0.00349	0.00401	CcSEcCtD
Nalidixic Acid—Vertigo—Alendronate—osteoporosis	0.00344	0.00395	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.00343	0.00393	CcSEcCtD
Nalidixic Acid—Angioedema—Ibandronate—osteoporosis	0.00341	0.00391	CcSEcCtD
Nalidixic Acid—Vertigo—Raloxifene—osteoporosis	0.00339	0.00389	CcSEcCtD
Nalidixic Acid—Vertigo—Ibandronate—osteoporosis	0.00335	0.00385	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.00334	0.00384	CcSEcCtD
Nalidixic Acid—Nausea—Calcium Acetate—osteoporosis	0.00332	0.00381	CcSEcCtD
Nalidixic Acid—Arthralgia—Estropipate—osteoporosis	0.00331	0.0038	CcSEcCtD
Nalidixic Acid—Paraesthesia—Etidronic acid—osteoporosis	0.0033	0.00378	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	0.00323	0.0037	CcSEcCtD
Nalidixic Acid—Arthralgia—Raloxifene—osteoporosis	0.00321	0.00368	CcSEcCtD
Nalidixic Acid—Arthralgia—Ibandronate—osteoporosis	0.00318	0.00365	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Estropipate—osteoporosis	0.00318	0.00364	CcSEcCtD
Nalidixic Acid—Convulsion—Calcitriol—osteoporosis	0.00317	0.00363	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Ibandronate—osteoporosis	0.00305	0.00349	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Raloxifene—osteoporosis	0.00301	0.00346	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Etidronic acid—osteoporosis	0.003	0.00344	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Calcitriol—osteoporosis	0.00298	0.00342	CcSEcCtD
Nalidixic Acid—Nausea—Ergocalciferol—osteoporosis	0.00293	0.00337	CcSEcCtD
Nalidixic Acid—Erythema—Pamidronate—osteoporosis	0.00292	0.00335	CcSEcCtD
Nalidixic Acid—Urticaria—Etidronic acid—osteoporosis	0.00292	0.00335	CcSEcCtD
Nalidixic Acid—Abdominal pain—Etidronic acid—osteoporosis	0.0029	0.00333	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00289	0.00332	CcSEcCtD
Nalidixic Acid—Angioedema—Ethinyl Estradiol—osteoporosis	0.00288	0.00331	CcSEcCtD
Nalidixic Acid—Paraesthesia—Estropipate—osteoporosis	0.00285	0.00327	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00285	0.00327	CcSEcCtD
Nalidixic Acid—Visual impairment—Conjugated Estrogens—osteoporosis	0.00285	0.00327	CcSEcCtD
Nalidixic Acid—Somnolence—Estropipate—osteoporosis	0.00282	0.00324	CcSEcCtD
Nalidixic Acid—Angioedema—Risedronate—osteoporosis	0.00281	0.00322	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.0028	0.00322	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.00279	0.0032	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00278	0.00318	CcSEcCtD
Nalidixic Acid—Vertigo—Risedronate—osteoporosis	0.00276	0.00317	CcSEcCtD
Nalidixic Acid—Paraesthesia—Ibandronate—osteoporosis	0.00274	0.00314	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00272	0.00312	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Estradiol—osteoporosis	0.0027	0.00309	CcSEcCtD
Nalidixic Acid—Angioedema—Pamidronate—osteoporosis	0.00267	0.00306	CcSEcCtD
Nalidixic Acid—Erythema—Zoledronate—osteoporosis	0.00267	0.00306	CcSEcCtD
Nalidixic Acid—Somnolence—Calcitriol—osteoporosis	0.00265	0.00304	CcSEcCtD
Nalidixic Acid—Arthralgia—Risedronate—osteoporosis	0.00262	0.003	CcSEcCtD
Nalidixic Acid—Leukopenia—Pamidronate—osteoporosis	0.00262	0.003	CcSEcCtD
Nalidixic Acid—Pruritus—Etidronic acid—osteoporosis	0.0026	0.00298	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Estropipate—osteoporosis	0.0026	0.00298	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Estradiol—osteoporosis	0.00258	0.00296	CcSEcCtD
Nalidixic Acid—Erythema—Conjugated Estrogens—osteoporosis	0.00257	0.00295	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Alendronate—osteoporosis	0.00256	0.00293	CcSEcCtD
Nalidixic Acid—Convulsion—Pamidronate—osteoporosis	0.00253	0.00291	CcSEcCtD
Nalidixic Acid—Urticaria—Estropipate—osteoporosis	0.00252	0.00289	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Raloxifene—osteoporosis	0.00252	0.00289	CcSEcCtD
Nalidixic Acid—Diarrhoea—Etidronic acid—osteoporosis	0.00251	0.00288	CcSEcCtD
Nalidixic Acid—Abdominal pain—Estropipate—osteoporosis	0.00251	0.00288	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Ibandronate—osteoporosis	0.00249	0.00286	CcSEcCtD
Nalidixic Acid—Arthralgia—Pamidronate—osteoporosis	0.00249	0.00286	CcSEcCtD
Nalidixic Acid—Urticaria—Alendronate—osteoporosis	0.00249	0.00285	CcSEcCtD
Nalidixic Acid—Abdominal pain—Alendronate—osteoporosis	0.00247	0.00284	CcSEcCtD
Nalidixic Acid—Angioedema—Zoledronate—osteoporosis	0.00244	0.0028	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Calcitriol—osteoporosis	0.00244	0.0028	CcSEcCtD
Nalidixic Acid—Abdominal pain—Raloxifene—osteoporosis	0.00243	0.00279	CcSEcCtD
Nalidixic Acid—Urticaria—Ibandronate—osteoporosis	0.00242	0.00278	CcSEcCtD
Nalidixic Acid—Abdominal pain—Ibandronate—osteoporosis	0.00241	0.00276	CcSEcCtD
Nalidixic Acid—Vertigo—Zoledronate—osteoporosis	0.0024	0.00275	CcSEcCtD
Nalidixic Acid—Leukopenia—Zoledronate—osteoporosis	0.00239	0.00274	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Pamidronate—osteoporosis	0.00239	0.00274	CcSEcCtD
Nalidixic Acid—Urticaria—Calcitriol—osteoporosis	0.00237	0.00272	CcSEcCtD
Nalidixic Acid—Abdominal pain—Calcitriol—osteoporosis	0.00236	0.0027	CcSEcCtD
Nalidixic Acid—Angioedema—Conjugated Estrogens—osteoporosis	0.00235	0.0027	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Pamidronate—osteoporosis	0.00234	0.00268	CcSEcCtD
Nalidixic Acid—Vomiting—Etidronic acid—osteoporosis	0.00233	0.00268	CcSEcCtD
Nalidixic Acid—Rash—Etidronic acid—osteoporosis	0.00231	0.00266	CcSEcCtD
Nalidixic Acid—Convulsion—Zoledronate—osteoporosis	0.00231	0.00265	CcSEcCtD
Nalidixic Acid—Dermatitis—Etidronic acid—osteoporosis	0.00231	0.00265	CcSEcCtD
Nalidixic Acid—Vertigo—Conjugated Estrogens—osteoporosis	0.00231	0.00265	CcSEcCtD
Nalidixic Acid—Headache—Etidronic acid—osteoporosis	0.0023	0.00264	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00229	0.00262	CcSEcCtD
Nalidixic Acid—Asthenia—Estropipate—osteoporosis	0.00228	0.00261	CcSEcCtD
Nalidixic Acid—Visual impairment—Estradiol—osteoporosis	0.00228	0.00261	CcSEcCtD
Nalidixic Acid—Arthralgia—Zoledronate—osteoporosis	0.00227	0.00261	CcSEcCtD
Nalidixic Acid—Paraesthesia—Risedronate—osteoporosis	0.00225	0.00259	CcSEcCtD
Nalidixic Acid—Pruritus—Estropipate—osteoporosis	0.00225	0.00258	CcSEcCtD
Nalidixic Acid—Asthenia—Alendronate—osteoporosis	0.00224	0.00257	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Estradiol—osteoporosis	0.00224	0.00256	CcSEcCtD
Nalidixic Acid—Convulsion—Conjugated Estrogens—osteoporosis	0.00223	0.00256	CcSEcCtD
Nalidixic Acid—Pruritus—Alendronate—osteoporosis	0.00221	0.00254	CcSEcCtD
Nalidixic Acid—Arthralgia—Conjugated Estrogens—osteoporosis	0.00219	0.00251	CcSEcCtD
Nalidixic Acid—Asthenia—Ibandronate—osteoporosis	0.00219	0.00251	CcSEcCtD
Nalidixic Acid—Nausea—Etidronic acid—osteoporosis	0.00218	0.0025	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Zoledronate—osteoporosis	0.00218	0.0025	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00217	0.00249	CcSEcCtD
Nalidixic Acid—Diarrhoea—Estropipate—osteoporosis	0.00217	0.00249	CcSEcCtD
Nalidixic Acid—Pruritus—Ibandronate—osteoporosis	0.00215	0.00247	CcSEcCtD
Nalidixic Acid—Paraesthesia—Pamidronate—osteoporosis	0.00214	0.00246	CcSEcCtD
Nalidixic Acid—Diarrhoea—Alendronate—osteoporosis	0.00214	0.00246	CcSEcCtD
Nalidixic Acid—Asthenia—Calcitriol—osteoporosis	0.00214	0.00245	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Zoledronate—osteoporosis	0.00213	0.00245	CcSEcCtD
Nalidixic Acid—Somnolence—Pamidronate—osteoporosis	0.00212	0.00243	CcSEcCtD
Nalidixic Acid—Pruritus—Calcitriol—osteoporosis	0.00211	0.00242	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00211	0.00242	CcSEcCtD
Nalidixic Acid—Diarrhoea—Raloxifene—osteoporosis	0.00211	0.00242	CcSEcCtD
Nalidixic Acid—Dizziness—Estropipate—osteoporosis	0.0021	0.00241	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.0021	0.00241	CcSEcCtD
Nalidixic Acid—Diarrhoea—Ibandronate—osteoporosis	0.00208	0.00239	CcSEcCtD
Nalidixic Acid—Dizziness—Alendronate—osteoporosis	0.00207	0.00237	CcSEcCtD
Nalidixic Acid—Erythema—Estradiol—osteoporosis	0.00206	0.00236	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Risedronate—osteoporosis	0.00205	0.00235	CcSEcCtD
Nalidixic Acid—Urticaria—Ethinyl Estradiol—osteoporosis	0.00205	0.00235	CcSEcCtD
Nalidixic Acid—Diarrhoea—Calcitriol—osteoporosis	0.00204	0.00234	CcSEcCtD
Nalidixic Acid—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00204	0.00233	CcSEcCtD
Nalidixic Acid—Dizziness—Raloxifene—osteoporosis	0.00203	0.00233	CcSEcCtD
Nalidixic Acid—Vomiting—Estropipate—osteoporosis	0.00202	0.00232	CcSEcCtD
Nalidixic Acid—Dizziness—Ibandronate—osteoporosis	0.00201	0.00231	CcSEcCtD
Nalidixic Acid—Rash—Estropipate—osteoporosis	0.002	0.0023	CcSEcCtD
Nalidixic Acid—Dermatitis—Estropipate—osteoporosis	0.002	0.0023	CcSEcCtD
Nalidixic Acid—Urticaria—Risedronate—osteoporosis	0.00199	0.00229	CcSEcCtD
Nalidixic Acid—Headache—Estropipate—osteoporosis	0.00199	0.00228	CcSEcCtD
Nalidixic Acid—Vomiting—Alendronate—osteoporosis	0.00199	0.00228	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00199	0.00228	CcSEcCtD
Nalidixic Acid—Abdominal pain—Risedronate—osteoporosis	0.00198	0.00228	CcSEcCtD
Nalidixic Acid—Rash—Alendronate—osteoporosis	0.00197	0.00226	CcSEcCtD
Nalidixic Acid—Dermatitis—Alendronate—osteoporosis	0.00197	0.00226	CcSEcCtD
Nalidixic Acid—Headache—Alendronate—osteoporosis	0.00196	0.00225	CcSEcCtD
Nalidixic Acid—Paraesthesia—Zoledronate—osteoporosis	0.00196	0.00225	CcSEcCtD
Nalidixic Acid—Vomiting—Raloxifene—osteoporosis	0.00196	0.00224	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Pamidronate—osteoporosis	0.00195	0.00224	CcSEcCtD
Nalidixic Acid—Rash—Raloxifene—osteoporosis	0.00194	0.00223	CcSEcCtD
Nalidixic Acid—Dermatitis—Raloxifene—osteoporosis	0.00194	0.00222	CcSEcCtD
Nalidixic Acid—Somnolence—Zoledronate—osteoporosis	0.00194	0.00222	CcSEcCtD
Nalidixic Acid—Vomiting—Ibandronate—osteoporosis	0.00194	0.00222	CcSEcCtD
Nalidixic Acid—Headache—Raloxifene—osteoporosis	0.00193	0.00221	CcSEcCtD
Nalidixic Acid—Rash—Ibandronate—osteoporosis	0.00192	0.0022	CcSEcCtD
Nalidixic Acid—Dermatitis—Ibandronate—osteoporosis	0.00192	0.0022	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00191	0.00219	CcSEcCtD
Nalidixic Acid—Headache—Ibandronate—osteoporosis	0.00191	0.00219	CcSEcCtD
Nalidixic Acid—Vomiting—Calcitriol—osteoporosis	0.0019	0.00217	CcSEcCtD
Nalidixic Acid—Nausea—Estropipate—osteoporosis	0.00189	0.00216	CcSEcCtD
Nalidixic Acid—Abdominal pain—Pamidronate—osteoporosis	0.00189	0.00216	CcSEcCtD
Nalidixic Acid—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00188	0.00216	CcSEcCtD
Nalidixic Acid—Angioedema—Estradiol—osteoporosis	0.00188	0.00216	CcSEcCtD
Nalidixic Acid—Rash—Calcitriol—osteoporosis	0.00188	0.00216	CcSEcCtD
Nalidixic Acid—Dermatitis—Calcitriol—osteoporosis	0.00188	0.00215	CcSEcCtD
Nalidixic Acid—Headache—Calcitriol—osteoporosis	0.00187	0.00214	CcSEcCtD
Nalidixic Acid—Somnolence—Conjugated Estrogens—osteoporosis	0.00187	0.00214	CcSEcCtD
Nalidixic Acid—Nausea—Alendronate—osteoporosis	0.00186	0.00213	CcSEcCtD
Nalidixic Acid—Vertigo—Estradiol—osteoporosis	0.00185	0.00212	CcSEcCtD
Nalidixic Acid—Asthenia—Ethinyl Estradiol—osteoporosis	0.00185	0.00212	CcSEcCtD
Nalidixic Acid—Nausea—Raloxifene—osteoporosis	0.00183	0.0021	CcSEcCtD
Nalidixic Acid—Pruritus—Ethinyl Estradiol—osteoporosis	0.00182	0.00209	CcSEcCtD
Nalidixic Acid—Nausea—Ibandronate—osteoporosis	0.00181	0.00208	CcSEcCtD
Nalidixic Acid—Asthenia—Risedronate—osteoporosis	0.0018	0.00207	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Zoledronate—osteoporosis	0.00178	0.00204	CcSEcCtD
Nalidixic Acid—Pruritus—Risedronate—osteoporosis	0.00178	0.00204	CcSEcCtD
Nalidixic Acid—Nausea—Calcitriol—osteoporosis	0.00177	0.00203	CcSEcCtD
Nalidixic Acid—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00176	0.00202	CcSEcCtD
Nalidixic Acid—Arthralgia—Estradiol—osteoporosis	0.00175	0.00201	CcSEcCtD
Nalidixic Acid—Urticaria—Zoledronate—osteoporosis	0.00173	0.00199	CcSEcCtD
Nalidixic Acid—Abdominal pain—Zoledronate—osteoporosis	0.00172	0.00198	CcSEcCtD
Nalidixic Acid—Diarrhoea—Risedronate—osteoporosis	0.00172	0.00197	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00172	0.00197	CcSEcCtD
Nalidixic Acid—Asthenia—Pamidronate—osteoporosis	0.00171	0.00196	CcSEcCtD
Nalidixic Acid—Dizziness—Ethinyl Estradiol—osteoporosis	0.0017	0.00195	CcSEcCtD
Nalidixic Acid—Pruritus—Pamidronate—osteoporosis	0.00169	0.00194	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Estradiol—osteoporosis	0.00168	0.00193	CcSEcCtD
Nalidixic Acid—Urticaria—Conjugated Estrogens—osteoporosis	0.00167	0.00191	CcSEcCtD
Nalidixic Acid—Dizziness—Risedronate—osteoporosis	0.00166	0.0019	CcSEcCtD
Nalidixic Acid—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00166	0.0019	CcSEcCtD
Nalidixic Acid—Vomiting—Ethinyl Estradiol—osteoporosis	0.00164	0.00188	CcSEcCtD
Nalidixic Acid—Diarrhoea—Pamidronate—osteoporosis	0.00163	0.00187	CcSEcCtD
Nalidixic Acid—Rash—Ethinyl Estradiol—osteoporosis	0.00162	0.00186	CcSEcCtD
Nalidixic Acid—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00162	0.00186	CcSEcCtD
Nalidixic Acid—Headache—Ethinyl Estradiol—osteoporosis	0.00161	0.00185	CcSEcCtD
Nalidixic Acid—Vomiting—Risedronate—osteoporosis	0.0016	0.00183	CcSEcCtD
Nalidixic Acid—Rash—Risedronate—osteoporosis	0.00158	0.00182	CcSEcCtD
Nalidixic Acid—Dermatitis—Risedronate—osteoporosis	0.00158	0.00181	CcSEcCtD
Nalidixic Acid—Dizziness—Pamidronate—osteoporosis	0.00158	0.00181	CcSEcCtD
Nalidixic Acid—Headache—Risedronate—osteoporosis	0.00157	0.0018	CcSEcCtD
Nalidixic Acid—Asthenia—Zoledronate—osteoporosis	0.00156	0.00179	CcSEcCtD
Nalidixic Acid—Pruritus—Zoledronate—osteoporosis	0.00154	0.00177	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00153	0.00176	CcSEcCtD
Nalidixic Acid—Nausea—Ethinyl Estradiol—osteoporosis	0.00153	0.00175	CcSEcCtD
Nalidixic Acid—Vomiting—Pamidronate—osteoporosis	0.00152	0.00174	CcSEcCtD
Nalidixic Acid—Paraesthesia—Estradiol—osteoporosis	0.00151	0.00173	CcSEcCtD
Nalidixic Acid—Asthenia—Conjugated Estrogens—osteoporosis	0.00151	0.00173	CcSEcCtD
Nalidixic Acid—Rash—Pamidronate—osteoporosis	0.0015	0.00173	CcSEcCtD
Nalidixic Acid—Dermatitis—Pamidronate—osteoporosis	0.0015	0.00172	CcSEcCtD
Nalidixic Acid—Headache—Pamidronate—osteoporosis	0.00149	0.00171	CcSEcCtD
Nalidixic Acid—Somnolence—Estradiol—osteoporosis	0.00149	0.00171	CcSEcCtD
Nalidixic Acid—Diarrhoea—Zoledronate—osteoporosis	0.00149	0.00171	CcSEcCtD
Nalidixic Acid—Nausea—Risedronate—osteoporosis	0.00149	0.00171	CcSEcCtD
Nalidixic Acid—Pruritus—Conjugated Estrogens—osteoporosis	0.00148	0.0017	CcSEcCtD
Nalidixic Acid—Dizziness—Zoledronate—osteoporosis	0.00144	0.00165	CcSEcCtD
Nalidixic Acid—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00144	0.00165	CcSEcCtD
Nalidixic Acid—Nausea—Pamidronate—osteoporosis	0.00142	0.00163	CcSEcCtD
Nalidixic Acid—Dizziness—Conjugated Estrogens—osteoporosis	0.00139	0.00159	CcSEcCtD
Nalidixic Acid—Vomiting—Zoledronate—osteoporosis	0.00139	0.00159	CcSEcCtD
Nalidixic Acid—Rash—Zoledronate—osteoporosis	0.00137	0.00158	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Estradiol—osteoporosis	0.00137	0.00158	CcSEcCtD
Nalidixic Acid—Dermatitis—Zoledronate—osteoporosis	0.00137	0.00158	CcSEcCtD
Nalidixic Acid—Headache—Zoledronate—osteoporosis	0.00137	0.00157	CcSEcCtD
Nalidixic Acid—Vomiting—Conjugated Estrogens—osteoporosis	0.00133	0.00153	CcSEcCtD
Nalidixic Acid—Urticaria—Estradiol—osteoporosis	0.00133	0.00153	CcSEcCtD
Nalidixic Acid—Abdominal pain—Estradiol—osteoporosis	0.00133	0.00152	CcSEcCtD
Nalidixic Acid—Rash—Conjugated Estrogens—osteoporosis	0.00132	0.00152	CcSEcCtD
Nalidixic Acid—Dermatitis—Conjugated Estrogens—osteoporosis	0.00132	0.00152	CcSEcCtD
Nalidixic Acid—Headache—Conjugated Estrogens—osteoporosis	0.00131	0.00151	CcSEcCtD
Nalidixic Acid—Nausea—Zoledronate—osteoporosis	0.00129	0.00149	CcSEcCtD
Nalidixic Acid—Nausea—Conjugated Estrogens—osteoporosis	0.00125	0.00143	CcSEcCtD
Nalidixic Acid—Asthenia—Estradiol—osteoporosis	0.00121	0.00138	CcSEcCtD
Nalidixic Acid—Pruritus—Estradiol—osteoporosis	0.00119	0.00136	CcSEcCtD
Nalidixic Acid—Diarrhoea—Estradiol—osteoporosis	0.00115	0.00132	CcSEcCtD
Nalidixic Acid—Dizziness—Estradiol—osteoporosis	0.00111	0.00127	CcSEcCtD
Nalidixic Acid—Vomiting—Estradiol—osteoporosis	0.00107	0.00123	CcSEcCtD
Nalidixic Acid—Rash—Estradiol—osteoporosis	0.00106	0.00121	CcSEcCtD
Nalidixic Acid—Dermatitis—Estradiol—osteoporosis	0.00106	0.00121	CcSEcCtD
Nalidixic Acid—Headache—Estradiol—osteoporosis	0.00105	0.00121	CcSEcCtD
Nalidixic Acid—Nausea—Estradiol—osteoporosis	0.000998	0.00114	CcSEcCtD
